For the approximately 15 million Americans that suffer from food allergies, good news is on the horizon: a lower-cost, generic version of EpiPen is to be released this week, and an even more affordable competitor will launch in 2017.
↧
For the approximately 15 million Americans that suffer from food allergies, good news is on the horizon: a lower-cost, generic version of EpiPen is to be released this week, and an even more affordable competitor will launch in 2017.